Literature DB >> 26174734

Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost.

Rashmi Krishnamurthy1, Sirisha Senthil1, Chandrasekhar S Garudadri1.   

Abstract

Topical latanoprost is a most effective and commonly used antiglaucoma medication. Use of prostaglandin analogues (PGA) in the early postoperative period is controversial due to its proinflammatory properties. We report a case of a 64-year-old man with primary open angle glaucoma, post-trabeculectomy 17 years prior, with good intraocular pressure (IOP) control on topical levobunolol 0.5% and latanoprost 0.005%. He underwent a clear corneal phacoemulsification surgery in his left eye and the PGA was stopped. He had an uneventful postoperative course and was prescribed eyeglasses at 4-week follow-up. Two weeks later, he presented to the emergency department with decreased vision in the left eye, flat anterior chamber, IOP of 00 mm Hg and 360° choroidal detachment. The continued use of topical latanoprost in the operated eye was implicated as the cause. This case illustrates the serious vision-threatening side effect of PGA when used in the early postoperative period. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26174734      PMCID: PMC4513540          DOI: 10.1136/bcr-2015-211408

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Choroidal detachment following extracapsular cataract extraction in a patient treated with latanoprost.

Authors:  R Gupta; S A Vernon
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

2.  Severe hypotony following cataract extraction in a patient on latanoprost.

Authors:  G Wu; A Morrell
Journal:  Eye (Lond)       Date:  2000-12       Impact factor: 3.775

3.  Acute angle-closure glaucoma associated with latanoprost.

Authors:  Ilgaz Sagdic Yalvac; Nevbahar Tamcelik; Sunay Duman
Journal:  Jpn J Ophthalmol       Date:  2003 Sep-Oct       Impact factor: 2.447

4.  Ciliochoroidal effusion induced by topical latanoprost in a patient with sturge-weber syndrome.

Authors:  Hiroshi Sakai; Nariko Sakima; Yoshimi Nakamura; Yuko Nakamura; Kazuhisa Hayakawa; Shoichi Sawaguchi
Journal:  Jpn J Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 2.447

5.  Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

Authors:  A Alm; J Stjernschantz
Journal:  Ophthalmology       Date:  1995-12       Impact factor: 12.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.